Welcome to the Funding Opportunities website. Below you will find a listing of various Funding Opportunities. Before applying, please make sure that you sign in, by clicking "Login" above. If you have never registered before, please create a new account. Creating an account will allow you to go back and make edits to your application.
Pilot Projects / Funding Opportunities
Alumni Relations Test Project
Deadline: 10/1/2018 (Prior to Midnight) - 12 Day(s) Left
This is a test project for the Office of Alumni Relations. This is used for testing purposes.
Project Title: WellSpan-Johns Hopkins Cancer Health Services Research Fund
Deadline: 11/12/2018 (Prior to Midnight) - 54 Day(s) Left
The Johns Hopkins University School of Medicine announces the inaugural requests for applications (RFA) for the WellSpan-Hopkins Cancer Health Services Research Fund. WellSpan-Hopkins awards will fund cancer health services research projects at the level of $100,000 direct costs per year, with an award term of one year.
Johns Hopkins-Allegheny Health Network Cancer Research Fund
Deadline: 11/15/2018 (Prior to Midnight) - 57 Day(s) Left
The Johns Hopkins University School of Medicine announces the fifth annual request for applications (RFA) for the Hopkins-Allegheny Health Network (AHN) Cancer Research Fund. Hopkins-AHN Awards will fund cancer research projects at the level of $100,000 direct costs per year, with an award term of two years.
The expectation is that Hopkins-AHN Awards will spark synergistic interactions among investigators and catalyze scientific achievements of the highest quality and impact. Applications are welcomed from across the spectrum of fundamental, translational, clinical, and epidemiologic research. Applications are similarly free to focus on specific organ sites or on issues that span multiple cancer types. Applications will be evaluated by reviewers from both the Sidney Kimmel Comprehensive Cancer Center (SKCCC) and the Allegheny Health Network Cancer Institute (AHN CI) and will be based on their potential to influence our scientific understanding of cancer and our clinical, operational, and financial management of the disease.